Clinical & Neuro Virology

Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019", states that the global clinical trial management systems market, which was worth US$844 million in 2013, will grow at a CAGR of 14% between 2013 and 2019 to acquire net worth of an estimated US$1,848.5 million by 2019.

Vector-borne diseases are infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, sandflies, blackflies,etc. A blood-borne disease  is one that can be spread through contamination by blood and other body fluids. RNA silencing controls gene expression to regulate development, genome stability and anxiety incited reactions. In plants, RNA silencing is also recognized as a major immune system targeted against plant viruses.

Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system.

  • Diagnostic methods in virology
  • Mechanism of Viral entry into the nervous system
  • Vector and Blood borne Diseases & Molecular Diagnosis of CNS Viral Infections
  • Aging and Metabolic Syndromes of Neurologic Disorders by Viruses
  • Tools used for diagnosing neuroviral infections

Related Conference of Clinical & Neuro Virology

Clinical & Neuro Virology Conference Speakers